Literature DB >> 27803113

Histopathological evaluation and expression of the pluripotent mesenchymal stem cell-like markers CD105 and CD44 in the synovial membrane of patients with primary versus secondary hip osteoarthritis.

Sabin Gligore Turdean1, Ioan Jung1, Simona Gurzu1, Ancuta Zazgyva2, Annamaria Fetyko1, Ciprian Oliviu Roman2, Mihai Turcu1, Tudor Sorin Pop2.   

Abstract

To present the morphological changes of classic primary versus rapidly progressive and secondary hip osteoarthritis (HO) and to examine the expression of two pluripotent mesenchymal stem cell-like markers in the synovial membrane. A prospective observational study was conducted in 57 consecutive cases of radiologically confirmed HO in which total hip arthroplasty was performed. Based on the radiological and clinicopathological features, the cases were divided into three categories: classic primary HO (group A; n=16), rapidly destructive HO (group B; n=24), and HO secondary to avascular osteonecrosis of the femoral head (group C; n=17). Immunostains were performed using the markers CD44 and CD105. The cases from group A were mainly characterized by a marked perivascular inflammatory infiltrate and simple synovial hyperplasia. In group B, the papillary type of synovial hyperplasia was found and presence of chondromatosis, ossification, and ectopic follicles with germinal centers in the subsynovial layer was characteristic, whereas marked calcification and/or ossification were seen in group C. Focal expression of the CD105 and CD44 was noted in the hyperplastic synovial cells and subsynovial layer in cases from group A, whereas synovial cells from group B were diffusely positive for both CD44 and CD105. In secondary HO, CD44 marked the inflammatory cells. Mobilization of the CD44/CD105 positive synovial cells seems to play a role in the genesis of HO. The number of the pluripotent mesenchymal stem cell-like cells derived from the hyperplastic synovial cells might be related to the severity of possible immune-mediated rapidly destructive HO.
Copyright © 2016 American Federation for Medical Research.

Entities:  

Keywords:  Osteoarthritis

Mesh:

Substances:

Year:  2016        PMID: 27803113     DOI: 10.1136/jim-2016-000244

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  3 in total

1.  Different synovial vasculogenic profiles of primary, rapidly destructive and osteonecrosis-induced hip osteoarthritis. An immunohistochemistry study.

Authors:  Simona Gurzu; Sabin Gligore Turdean; Sorin Tudor Pop; Ancuta Zazgyva; Ciprian Oliviu Roman; Mihaela Opris; Ioan Jung
Journal:  Int Orthop       Date:  2016-10-04       Impact factor: 3.075

2.  IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20.

Authors:  MÁrcia UchÔa DE Rezende; Henrique Melo Campos Gurgel; Guilherme Pereira Ocampos; Gustavo Constantino DE Campos; Renato Frucchi; Alexandre FelÍcio Pailo; Thiago Pasqualin; JosÉ Ricardo Negreiros Vicente; Olavo Pires DE Camargo
Journal:  Acta Ortop Bras       Date:  2020 Nov-Dec       Impact factor: 0.513

Review 3.  Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases.

Authors:  Na Li; Jinfang Gao; Liangyu Mi; Gailian Zhang; Liyun Zhang; Na Zhang; Rongxiu Huo; Junping Hu; Ke Xu
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.